drugset / Trial / NCT04219046

Evaluation of Naloxegol in the Prevention of POI After Cystectomy

NCT04219046

Phase 2 Unknown 102 enrolled Institut Paoli-Calmettes
RandomizedParallel-groupTriple-blindTreatment

Summary

Postoperative ileus (POI) is defined as a transient reduction of bowel motility that prevents effective transit of bowel content and tolerance of oral intake following surgical interventions, especially after radical cystectomy. It remains a major factor associated with postoperative morbidity, length of hospital stay and medical costs. In order to optimize perioperative care for patients undergoing radical cystectomy in a context of an ERAS (Enhanced Recovery After Surgery) program, we will evaluate the effectiveness of systemic pharmacologic opioid antagonist treatment.

Timeline

Start
2021-03
Primary completion
2022-09
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxegol Small molecule 25 mg Oral